Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2010 / Cilt: 56 - Sayı: 3

Wilson's disease presented with severe low back and hip pain as initial symptoms and subsequent involuntary movements: A case report

Şiddetli bel ve kalça ağrısı ile başlayan ve istemsiz hareketlerin eklendiği wilson hastalığı: Olgu sunumu

Pages
141–144
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Wilson’s disease should be kept in mind in patients with arthropathy and also hepatic or neurologic symptoms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A forty-six-year-old male patient was admitted to the hospital with complaints of severe low back and hip pain as well as involuntary body and limb movements.
📊
Key Findings & Data:MRI of the hip and sacroiliac joints demonstrated sacroiliac joint effusion, bone marrow edema in both femoral heads, and bilateral psoas bursitis.
💡
Conclusion & Impact:Wilson’s disease should be kept in mind in patients with arthropathy and also hepatic or neurologic symptoms.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A forty-six-year-old male patient was admitted to the hospital with complaints of severe low back and hip pain as well as involuntary body and limb movements. Physical examination revealed left-sided hemiballismus, limited and painful movements of the low back, hip and sacroiliac joints, and Kayser-Fleischer ring on eye examination. Magnetic resonance imaging (MRI) findings of the cranium and lumbar spine were normal. MRI of the hip and sacroiliac joints demonstrated sacroiliac joint effusion, bone marrow edema in both femoral heads, and bilateral psoas bursitis. Hypometabolism was found in the right basal ganglia on Flourodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT). Hepatic and neurologic symptoms are the first manifestation of Wilson’s disease in 30-40% of patients. Wilson disease is one of well known cause of arthropathy, however this is very rare condition. Wilson’s disease should be kept in mind in patients with arthropathy and also hepatic or neurologic symptoms.

Özet

Şiddetli bel, kalça ağrısı ve istemsiz hareketler şikayeti ile hastanemize başvuran 46 yaşında erkek hastanın muayenesinde solda hemibalismus ve ileri derecede kısıtlı ve ağrılı lomber, kalça ve sakroiliak eklem hareketleri bulundu. Kraniyumun ve lomber vertebranın Manyetik Rezonans Görüntüleme (MRG) incelemelerinde özellik saptanmayan hastanın kalça ve sakroiliyak eklem MRG tetkiklerinde sakroiliyak eklemlerde sıvı artışı, her iki femur başında kemik iliği ödemi ve bilateral psoas bursiti saptandı. Flordeoksiglukoz positron emisyon tomografi/ bilgisayarlı tomografi(FDG PET/CT) incelemesinde sağ bazal gangliyonda hipometabolizma bulundu. Göz muayenesinde Kayser-Fleischer halkaları tespit edildi. Wilson hastalığı %30-40 oranında nörolojik semptomlar ve %30-40 oranında hepatik bulgularla kendini gösterir. Wilson hastalığının artropatiye sebep olduğu bilinen bir gerçek olmasına rağmen, bu ender görülen bir durumdur.Nörolojik veya hepatik semptomlar ve bulguların eşliğinde artropati bu hastalığı akla getirmelidir.

🔖

Cite This Article

KAYA, M., KANBEROĞLU, K., ÜNALAN, H., ALİMGİL, L., BOTANLIOĞLU, H., MAJLESİ, J., ÇEVİK, D. M., MENGİ, N., BİNGÖL, H. (2022). Wilson's disease presented with severe low back and hip pain as initial symptoms and subsequent involuntary movements: A case report. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 56 - Sayı: 3, 141–144. https://ajindex.com/articles/629051

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (21)

  1. Chin-to Fong MD. Nutritional Disorders, Mineral Deficiency and Toxicity, Wilson's Diease. In: Beers M.H, Berkow R, editors. The Merck Manual. 17th Edition. Merck Research Laboratories, N.J; 1999. p. 56-8
  2. Medici V, Revisan CP, D'Incà R, Barollo M, Zancan L, Fagiuoli S et al. Diagnosis and management of Wilson's diaease: results of a single center experience. J Clin Gastroenterol 2006;40:936-41
  3. El-Youssef M. Wilson disease. Myo Clin Proc 2003;78:1126-36
  4. Brewer GJ. Recognition, diagnosis, and management of Wilson's disease. Proc Soc Exp Biol Med. 2000;223:39-46
  5. Brewer GJ. Practical recommendations and new therapies for Wilson's disease. Drugs. 1995;50:240-9
  6. Yarze JC, Martin P, Munoz SJ, Freidman LS. Wilson's disease: current status. Am J Med 1992;92:643-54
  7. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine (Baltimore). Review 1992;71:139-64
  8. Toncev J, Beslin M, Jevdic D. Case reposrts of patients with hepatolenticular degeneration-Wilson's disease with emphasis on work capacity. Med Pregl 1989;42:33-5
  9. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007;369:397-408
  10. Banhamla T, Tirouche YD, Abaoud-Germain A, Theodore F. The onset of Psychiatric disorders and Wilson's diseasse. Encephale 2007;33:924-32
  11. Schilsky ML. Wilson disease: new insights into pathogenesis, and future therapy. Curr Gastroenterol Rep 2005;7:26-31
  12. Marle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long- term outcome of Wilson's disease: a cohort study. Gut 2007;56:115-20
  13. Pfeiffer RF. Wilson's Disease. Semin Neurol 2007;27:123-32
  14. Das SK, Ray K. Wilson's disease: an update. Nat Clin Pract Neurol 2006;2:482-93
  15. Seo JK. Wilson disease: an update. Korean J Hepatol. 2006;12:333-63
  16. Mak CM, Lam CW. Diagnosis of Wilson's disease: a comprehensive review. Crit Rev Clin Lab Sci 2008;45:263-90
  17. Ferenci P. Wilson's disease. Clin Liver Dis. v-vi. 1998;2:31-49
  18. Willeit J, Kiechi SG, Birbamer G, Schmidauer C, Fleber S, Aichner F et al. Wilson's disease with primary CNS manifestation-current status in diagnosis and therapy. Fortschr Neurol Psychiatr. 1992;60:237-45
  19. Kitzberger R, Madl C, Ferenci P. Wilson disease. Metab Brain Dis. 2005;20:295-302
  20. Brewer GJ. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment. CNS Drugs. 2005;19:185-92
  21. Jackson GH, Meyer A, Lippmann S. Wilson's disease. Psychiatric manifestations may be the